Early Refill of Schedule II Stimulant and Corresponding Responsibility
A 28-year-old male presents to your community pharmacy on day 24 of a 30-day supply of lisdexamfetamine 70 mg with a new prescription for the same drug and dose written by a different prescriber in a different city. The patient says he is moving and needs the medication early because he will be traveling. The original prescriber's office is closed. The patient's profile shows the same pattern for the last three months: early refills, different prescribers, and payment with cash. The PDMP shows the patient received the same drug from three different pharmacies in the past 60 days, with overlapping days' supply. The patient becomes agitated when you ask about the other prescribers and demands the fill. What do you do?
1. What are the key red flags for diversion, and what does Texas law require you to do before dispensing?
Read the worked answer
Red flags: early refill (day 24 of 30), different prescribers, different pharmacies, cash payment, overlapping days' supply, and patient agitation. Under Texas Health & Safety Code §481.074 and 22 TAC §315.6, a pharmacist may not dispense a controlled substance if the pharmacist knows or should have known that the prescription is not for a legitimate medical purpose. The pharmacist has a corresponding responsibility to resolve red flags. Before dispensing, you must attempt to verify the prescription with the prescriber, check the PDMP, and document your findings. If you cannot resolve the red flags, you must refuse to fill. You should also consider reporting to the Texas State Board of Pharmacy and possibly law enforcement if diversion is suspected.
2. If you refuse to fill, what are your obligations regarding the prescription and the patient?
Read the worked answer
You must return the prescription to the patient (or notify the prescriber) and document the refusal in the patient's record, including the reason. You should not confiscate the prescription. You should advise the patient to contact the prescriber. You may also report the pattern to the prescriber and to the Board. Under 22 TAC §291.33, pharmacist-in-charge must ensure that a system is in place for resolving red flags. Refusing to fill based on a legitimate concern is protected; however, you must not discriminate against the patient. Document everything.